Press Releases June 24, 2026 10:00 PM

Guest Supply Signs Asia-Pacific Licensing Agreement with RODA

Guest Supply, a Sysco subsidiary, partners with RODA to distribute skincare products in Asia-Pacific hotels

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
SYY

Guest Supply, part of Sysco Corporation, has signed a licensing agreement with Barcelona-based skincare brand RODA to manufacture and distribute RODA-branded skincare and personal care products for the hotel sector across the Asia-Pacific region. This partnership leverages Guest Supply's hospitality manufacturing and distribution capabilities alongside RODA's clinically formulated, sustainable skincare products, aiming to enhance the in-room experience for hotels in APAC.

Guest Supply Signs Asia-Pacific Licensing Agreement with RODA
SYY
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Guest Supply leverages its distribution and manufacturing network to expand RODA’s presence in Asia-Pacific hotels.
  • RODA's products combine natural ingredients with dermatological expertise, focusing on sensitive skin and sustainability.
  • The agreement aims to ensure quality assurance, scalable supply, and simplified ordering for hotel partners through Guest Supply’s supply chain.

HONG KONG, June 25, 2026 (GLOBE NEWSWIRE) -- Guest Supply today announced a licensing agreement with RODA to manufacture and distribute RODA-branded skincare and personal care products across Asia Pacific for the hotel sector.

The agreement combines Guest Supply’s hospitality manufacturing, distribution and service capabilities with RODA’s clinically formulated approach to skin and hair care. Created in Barcelona, RODA develops products with sensitive skin in mind and designs its formulas to be suitable for all skin types.

RODA combines natural active ingredients with advanced research, technology and a sustainability-led approach. Its development model draws on ingredient analysis, scientific literature and product-review insights, supporting exclusive formulas created in-house with pharmacists and dermatological experts.

“RODA brings a distinctive, clinically formulated skincare proposition grounded in innovation, which will resonate with hotels looking to elevate the in-room experience,” said Gustaf Lantz, senior vice president, EMEA and APAC regions, Guest Supply. “Through Gilchrist & Soames’ manufacturing and quality expertise and Guest Supply’s distribution capabilities across Asia Pacific, we can ensure brand integrity, reliable availability and make it easier for hotels to deliver a premium, performance-led amenity program at scale.”

Under the agreement, Guest Supply will align RODA collections to hospitality operating requirements while maintaining brand standards. This includes quality assurance, scalable supply and simplified ordering for hotel partners through Guest Supply’s established supply chain.

RODA is selectively distributed globally through dermatology clinics, concept stores and select hotels. Through this APAC licensing partnership, Guest Supply will expand access for hospitality customers across the region.

About Guest Supply

With more than 40 years of experience, Guest Supply is a leader in hospitality supplies, serving major hotel chains and independent properties. As part of Sysco Corporation, it provides product development, manufacturing, distribution and service support.

About RODA

RODA is a Barcelona-based dermatological beauty brand inspired by the Mediterranean lifestyle and built on a data-driven approach to formulation. The brand combines natural active ingredients with advanced research to deliver effective, vegan and sustainability-minded skincare and haircare.

Media Contact: Ramit Plushnick-Masti, [email protected]

[Website: www.guestsupply.com.hk]

SYY-NEWS


Risks

  • Dependence on hotel and hospitality sector recovery and growth in the Asia-Pacific region.
  • Potential challenges in maintaining brand standards and quality while scaling production and distribution.
  • Competitive skincare and in-room hospitality product markets that could limit market penetration.

More from Press Releases

Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants Jun 24, 2026 REalloys Inc. (Nasdaq: ALOY) Announces Private Placement of Common Stock for Gross Proceeds of Approximately $100 Million Jun 24, 2026 Mesoblast Draws US$50 Million from Five-Year Non-Dilutive Facility Jun 24, 2026 NANO Nuclear Highlights Global Strategic Engagements Across Emerging Nuclear Markets and Management Team Updates Jun 24, 2026 HUTCHMED Highlights Pivotal Phase II Data for Fanregratinib in Intrahepatic Cholangiocarcinoma Presented at ESMO Gastrointestinal Cancers Congress 2026 Jun 24, 2026